If your antidepressant doesn't seem to be working, you're in common company. Studies suggest that about one-third of people don't respond adequately to their first antidepressant, and the landmark STAR*D trial found that only about 50% of people with depression achieved remission after trying two different medications. The good news is that there are concrete reasons this happens, and understanding them can help you and your doctor find a better path forward.
If you are experiencing suicidal thoughts, thoughts of self-harm, or feel that life isn't worth living, please reach out immediately. Call 988 (Suicide and Crisis Lifeline), text HOME to 741741 (Crisis Text Line), or go to your nearest emergency room. You deserve help, and help is available right now.
Most antidepressants take 4 to 8 weeks to reach their full effect. During the first few weeks, you may experience side effects before any therapeutic benefit. This is one of the hardest parts of starting treatment, but many people who feel nothing at week 2 feel significantly better at week 6.
There are over 20 different antidepressants across multiple classes (SSRIs, SNRIs, TCAs, atypical antidepressants), and they all work somewhat differently. The first one your doctor tries may simply not be the right fit for your brain chemistry. Additionally, many people are underdosed because titration stopped too early.
Treatment-resistant depression may actually be bipolar depression (which requires different medication), may coexist with anxiety or PTSD, or may be complicated by thyroid problems, sleep disorders, or chronic pain. These comorbidities can make standard antidepressant treatment less effective.
Medication alone is often not sufficient. Sleep quality, exercise, alcohol use, stress levels, and social support all significantly impact depression outcomes. Combining medication with therapy (particularly CBT) has consistently shown better results than either alone.
A growing body of evidence shows that your genes play a substantial role in how you respond to antidepressants. Two key liver enzymes, CYP2C19 and CYP2D6, are responsible for metabolizing most antidepressants. Variations in these genes affect drug levels in your body and can explain why the same antidepressant works wonderfully for one person and does nothing for another.
CYP2C19 is the primary enzyme for metabolizing SSRIs like sertraline (Zoloft), escitalopram (Lexapro), and citalopram (Celexa). Ultrarapid metabolizers (5-30% of people, depending on ancestry) may clear these drugs too fast for them to work. Poor metabolizers (2-15%) clear them too slowly, increasing side effects.
CYP2D6 metabolizes SNRIs like venlafaxine (Effexor), tricyclics like amitriptyline, and several SSRIs including paroxetine (Paxil) and fluvoxamine (Luvox). About 5-10% of Caucasians are poor metabolizers, and 1-2% are ultrarapid metabolizers, significantly affecting how these drugs work.
If you're an ultrarapid metabolizer of CYP2C19, SSRIs like sertraline and escitalopram may never reach therapeutic levels at standard doses. If you're a poor metabolizer of CYP2D6, drugs like venlafaxine and paroxetine may accumulate to levels that cause intolerable side effects. Pharmacogenetic testing can map your metabolizer status for both enzymes, helping your doctor choose the antidepressant and dose most likely to work for your specific genetic profile.
Pharmacogenetic testing is especially valuable if you've tried two or more antidepressants without adequate response, if you've experienced significant side effects across multiple medications, or if you have a family history of antidepressant treatment difficulties. Several large studies, including the GUIDED trial, have shown that pharmacogenetic-guided treatment leads to better outcomes than standard trial-and-error prescribing.
Learn how genetics may affect your response to these related medications:
About 30-40% of people don't respond adequately to their first antidepressant. The STAR*D study, the largest antidepressant trial ever conducted, found that remission rates drop with each successive medication trial, making it important to make informed choices earlier in treatment.
A pharmacogenetic test reveals how your body metabolizes different antidepressants, which helps predict which ones are more or less likely to work at standard doses. It doesn't guarantee a specific response, but it eliminates medications that are genetically unlikely to work for you, narrowing the field significantly.
Yes, it's very common. Most psychiatrists expect some degree of trial and adjustment. However, pharmacogenetic testing can reduce the number of trials needed by identifying medications that match your metabolic profile from the start.
Find out how your DNA may influence your response to Sertraline and other medications with a Gene2Rx pharmacogenetics report.
Get Your Report Try Our Free Calculator